Journal Article
R. L. H. Handels, Sköldunger, A., Bieber, A., Edwards, R. Tudor, Gonçalves-Pereira, M., Hopper, L., Irving, K., Jelley, H., Kerpershoek, L., Marques, M. J., Meyer, G., Michelet, M., Portolani, E., Røsvik, J., Selbaek, G., Stephan, A., de Vugt, M., Wolfs, C., Woods, B., Zanetti, O., Verhey, F., and Wimo, A.,
“Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”,
J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
P. Liu, Reichl, J. H., Rao, E. R., McNellis, B. M., Huang, E. S., Hemmy, L. S., Forster, C. L., Kuskowski, M. A., Borchelt, D. R., Vassar, R., Ashe, K. H., and Zahs, K. R.,
“Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 743-761, 2017.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M.,
“Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M.,
“Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
C. Groot, Tolboom, N., Ikonomovic, M. D., Lammertsma, A. A., Boon, B. D. C., Barkhof, F., Scheltens, P., Klunk, W. E., Rozemuller, A. J. M., Ossenkoppele, R., and van Berckel, B. N. M.,
“Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma.”,
J Alzheimers Dis, 2018.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G.,
“Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”,
J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
A. Vojdani, Vojdani, E., Saidara, E., and Kharrazian, D.,
“Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
A. Vojdani, Vojdani, E., Saidara, E., and Kharrazian, D.,
“Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
P. Sachdeva, Narayanan, K. Badri, Sinha, J. Kumar, Gupta, S., Ghosh, S., Singh, K. Kumar, Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. Kumar, Nelson, V. Kumar, Paiva-Santos, A. Cláudia, Abomughaid, M. Mohammad, Kamal, M., Iqbal, D., ALHarbi, M. Hamoud, ALMutairi, A. Aedh, Dewanjee, S., Nuli, M. Vamsi, Vippamakula, S., Jha, S. Kumar, Ojha, S., and Jha, N. Kumar,
“Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
R. García de Eulate, Goñi, I., Galiano, A., Vidorreta, M., Recio, M., Riverol, M., Zubieta, J. L., and Fernández-Seara, M. A.,
“Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI.”,
J Alzheimers Dis, vol. 58, no. 2, pp. 585-595, 2017.
B. Soukupova Urbanova, Schwabova, J. Paulasova, Magerova, H., Jansky, P., Marková, H., Vyhnálek, M., Laczó, J., Hort, J., and Tomek, A.,
“Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 465-477, 2018.
L. D. Estrada, Chamorro, D., Yañez, M. José, Gonzalez, M., Leal, N., von Bernhardi, R., Dulcey, A. E., Marugan, J., Ferrer, M., Soto, C., Zanlungo, S., Inestrosa, N. C., and Alvarez, A. R.,
“Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”,
J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
A. Alghamdi, Vallortigara, J., Howlett, D. R., Broadstock, M., Hortobágyi, T., Ballard, C., Thomas, A. J., O'Brien, J. T., Aarsland, D., Attems, J., Francis, P. T., and Whitfield, D. R.,
“Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia.”,
J Alzheimers Dis, vol. 57, no. 2, pp. 373-386, 2017.
A. Vipin, Foo, H. Jing Ling, Lim, J. Kai Wei, Chander, R. Jude, Yong, T. Ting, Ng, A. Su Lyn, Hameed, S., Ting, S. Kang Seng, Zhou, J., and Kandiah, N.,
“Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 533-549, 2018.
W. Gomm, von Holt, K., Thomé, F., Broich, K., Maier, W., Weckbecker, K., Fink, A., Doblhammer, G., and Haenisch, B.,
“Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 801-8, 2016.
B. L. R. Reijs, Ramakers, I. H. G. B., Elias-Sonnenschein, L., Teunissen, C. E., Koel-Simmelink, M., Tsolaki, M., Wahlund, L. - O., Waldemar, G., Hausner, L., Johannsen, P., Vanderstichele, H., Verhey, F., Devanand, D. P., and Visser, P. Jelle,
“Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”,
J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
B. L. R. Reijs, Ramakers, I. H. G. B., Elias-Sonnenschein, L., Teunissen, C. E., Koel-Simmelink, M., Tsolaki, M., Wahlund, L. - O., Waldemar, G., Hausner, L., Johannsen, P., Vanderstichele, H., Verhey, F., Devanand, D. P., and Visser, P. Jelle,
“Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”,
J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
B. L. R. Reijs, Ramakers, I. H. G. B., Elias-Sonnenschein, L., Teunissen, C. E., Koel-Simmelink, M., Tsolaki, M., Wahlund, L. - O., Waldemar, G., Hausner, L., Johannsen, P., Vanderstichele, H., Verhey, F., Devanand, D. P., and Visser, P. Jelle,
“Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”,
J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
C. Dang, Harrington, K. D., Lim, Y. Ying, Ames, D., Hassenstab, J., Laws, S. M., Yassi, N., Hickey, M., Rainey-Smith, S., Robertson, J., Sohrabi, H. R., Salvado, O., Weinborn, M., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P.,
“Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.”,
J Alzheimers Dis, vol. 65, no. 4, pp. 1313-1325, 2018.
J. Blautzik, Kotz, S., Brendel, M., Sauerbeck, J., Vettermann, F., Winter, Y., Bartenstein, P., Ishii, K., and Rominger, A.,
“Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 65, no. 3, pp. 781-791, 2018.
A. G. Andrade, Bubu, O. M., Varga, A. W., and Osorio, R. S.,
“The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.”,
J Alzheimers Dis, vol. 64, no. s1, pp. S255-S270, 2018.
E. Marina Gon Cordero, Cuevas-Budhart, M. Angel, Morán, D. Pérez, Villeda, M. Angel Trej, and Gª-Madrid, M. Gomez- Del-,
“Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.”,
J Alzheimers Dis, vol. 87, no. 2, pp. 519-528, 2022.
] Year 